Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 04 Jan 2022 for Ampio Pharmaceuticals, Inc., €24k.
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Holli Cherevka: trading record in brief
This profile gathers the share dealings of Holli Cherevka in Ampio Pharmaceuticals, Inc., where the filings describe the role as chief executive. In total, 8 filings cover trades dated from 27 April 2021 to 1 January 2022.
No open-market purchase appears, only 2 sales worth €128k. The rest of the record consists of 3 share grants and 3 option exercises.
Most recently, on 4 January 2022, the filings show a share grant worth €24k in Ampio Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Holli Cherevka
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
47,200 shares@ US$0.5728.2% of flowCommon StockSEC:0001415889-22-000258:0
41,980 shares@ US$1.6470.5% of flowCommon StockSEC:0001415889-21-005018:0
500,000 shares0Common StockSEC:0001415889-21-004868:0
2,603 shares@ US$0.511.3% of flowCommon StockSEC:0001415889-21-002667:0
4 of 4 declarations
